Cidara Therapeutics (CDTX) Stock Chart & Stock Price History $22.84 -1.42 (-5.85%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$22.63 -0.21 (-0.92%) As of 06/13/2025 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cidara Therapeutics Stock Price Performance The Cidara Therapeutics (CDTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 69.94%, with a year-to-date return of -15.03%. In the past month, the stock has increased 18.28%, reflecting recent market activity. As of the latest close, Cidara Therapeutics traded at $22.84 with a market cap of $286.57 million and volume of 239,404 shares. Five years ago, the stock traded at a split-adjusted price of $73.40, representing a 68.88% decrease over that period. At the time, it had a market cap of $153.36 million and a volume of 7,021 shares. Receive CDTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-10.01%1 Month Performance+18.28%3 Month Performance+3.58%Year-To-Date Performance-15.03%1 Year Performance+69.94%5 Year Performance-68.88% CDTX Stock Chart for Saturday, June, 14, 2025 CDTX Chart by TradingView Cidara Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$24.26$22.84-5.85%$24.19$22.84239,404 shs$286.57 million06/12/2025$25.93$24.26-6.44%$25.94$24.20151,195 shs$304.39 million06/11/2025$26.17$25.93-0.92%$27.00$25.30318,116 shs$325.34 million06/10/2025$25.38$26.17+3.11%$26.19$23.89248,764 shs$328.36 million06/09/2025$25.22$25.38+0.63%$25.87$23.56252,945 shs$318.44 million06/06/2025$24.05$25.22+4.86%$25.30$23.85192,832 shs$316.44 million06/05/2025$24.05$24.05$25.06$23.58225,731 shs$301.76 million06/04/2025$23.30$24.05+3.22%$24.77$23.73363,087 shs$301.76 million06/03/2025$22.67$23.30+2.78%$23.62$22.5078,993 shs$292.35 million06/02/2025$22.06$22.67+2.77%$22.94$21.46188,485 shs$284.44 million Get the Latest News and Ratings for CDTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$22.02$22.06+0.18%$22.35$21.57116,386 shs$276.79 million05/29/2025$22.69$22.02-2.95%$22.78$21.58111,906 shs$276.29 million05/28/2025$24.00$22.69-5.46%$24.91$21.84186,714 shs$284.69 million05/27/2025$24.28$24.00-1.15%$24.65$22.96170,081 shs$301.13 million05/26/2025$24.28$24.28$25.95$24.12163,459 shs$304.64 million05/23/2025$25.70$24.28-5.53%$25.95$24.12163,459 shs$304.64 million05/22/2025$26.25$25.70-2.10%$26.55$25.21159,840 shs$322.46 million05/21/2025$26.90$26.25-2.42%$27.00$25.29262,620 shs$329.36 million05/20/2025$26.49$26.90+1.55%$27.49$25.82285,417 shs$337.51 million05/19/2025$25.50$26.49+3.88%$27.64$24.18382,370 shs$332.37 million05/16/2025$21.04$25.50+21.20%$25.58$21.48278,728 shs$319.95 million05/15/2025$19.31$21.04+8.96%$21.19$19.10277,111 shs$263.99 million05/14/2025$19.36$19.31-0.26%$19.50$18.9166,246 shs$242.28 million05/13/2025$19.43$19.36-0.36%$20.13$19.1664,180 shs$242.91 million05/12/2025$18.50$19.43+5.03%$20.29$18.69216,524 shs$243.79 million Related Companies Aurinia Pharmaceuticals Stock Chart CureVac Stock Chart Mineralys Therapeutics Stock Chart Phibro Animal Health Stock Chart Arcus Biosciences Stock Chart Wave Life Sciences Stock Chart Syndax Pharmaceuticals Stock Chart Collegium Pharmaceutical Stock Chart Enliven Therapeutics Stock Chart Spyre Therapeutics Stock Chart Receive CDTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CDTX) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s worst nightmareThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cidara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CDTX Stock Free CDTX Stock Alerts